# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Booker T. Washington (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI017-SYN-TD
- Date: 1915-05-04
- Fictional facility: St. Posthumous Health Center
- Fictional author: Lorraine Whitfield, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## What we are working on

- Frontal headaches every week or so, palpitations, and fatigue are cutting into his workday **S**
- Worried about blurred reading vision and getting up at night to urinate **S**
- Wants a plan that fits a heavy travel schedule **S**

## Your goals

- Lower blood pressure below 130/80 within two months. Target: 1915-06-29. Recorded outcome: Blood pressure 128/80 on four medicines. **S**
- Reach a standardized office systolic pressure below 120 when tolerated by the six-month review. Target: 1915-10-26. Recorded outcome: Blood pressure 118/76 without dizziness. **S**
- Reduce the urine albumin-creatinine ratio by at least 30 percent by the six-month review. Target: 1915-10-26. Recorded outcome: UACR fell from 820 to 240 mg/g. **S**
- Keep eGFR decline after starting therapy within 30 percent and stable thereafter. Target: 1915-10-26. Recorded outcome: eGFR 36 at baseline, 30 on full therapy, 32 at six months. **S**

## What we agreed to do

- Treat severe hypertension without acute target-organ damage as an outpatient: start losartan and amlodipine together, check home blood pressure twice daily, and go to the emergency department for chest pain, shortness of breath, weakness, confusion, or vision loss. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025) **S**
- Nephrology referral for eGFR below 60 with severely increased albuminuria (UACR above 300 mg/g) and stage 2 hypertension. Guideline: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and chronic kidney disease monographs (2026) **S**
- Titrate losartan to the maximum tolerated dose and add an SGLT2 inhibitor for CKD with UACR of at least 200 mg/g; accept a creatinine rise of up to 30 percent. Guideline: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021) **S**
- Add chlorthalidone if blood pressure stays above target on two agents; avoid NSAIDs and review every medication dose for kidney function. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021) **S**
- Check potassium and creatinine one to four weeks after each renin-angiotensin, SGLT2 inhibitor, or diuretic change; then eGFR and UACR about three times a year for G3b A3, hemoglobin at least yearly, and calcium, phosphate, and PTH every six to twelve months; recalculate the kidney failure risk yearly. Guideline: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and chronic kidney disease monographs (2026) **S**
- Moderate-intensity statin for an adult aged 50 or older with eGFR below 60; no routine repeat LDL. Guideline: KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024); CMID: Clinical Monitoring Intelligence Database, hypertension and chronic kidney disease monographs (2026) **S**
- Sodium below 2 g a day with a plan for meals while traveling; at least 150 minutes of activity a week. Guideline: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults (2025); KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024) **S**
- Annual dilated eye examination for hypertensive retinopathy; pneumococcal and hepatitis B vaccination for chronic kidney disease. Guideline: CMID: Clinical Monitoring Intelligence Database, hypertension and chronic kidney disease monographs (2026) **S**

## Follow-up

- 1915-05-04: Primary care visit for headaches, fatigue, and a very high blood pressure **S**
- 1915-05-11: One-week blood pressure and kidney safety check with nephrology consultation **S**
- 1915-06-01: Three-week check after losartan titration and dapagliflozin start **S**
- 1915-06-29: Four-week check after adding chlorthalidone **S**
- 1915-09-21: Periodic adult preventive visit **S**
- 1915-10-26: Six-month blood pressure and chronic kidney disease review **S**

This teaching document does not replace care from a qualified clinician.
